During metastasis, the IRE1α-XBP1 pathway interacts with HIF1α (Hypoxia-inducible factor 1-alpha) to promote tumor growth and survival in hypoxia, making it a potential target for treating metastatic cancer [35]. The gene discussed is HIF1A; the disease is neoplasm.